Collagen & Gelatin Market for Regenerative Medicine

Growth Factors Driving the Market: The Growth in the collagen and gelatin market is driven by factors such as the rising prevalence of target diseases and disorders, rising number of surgeries coupled with growing geriatric population, and investments in R&D. However, the availability of efficient and reliable substitute biomaterials is expected to restrain the market growth during the forecast period

The 21st Century Cures Act was signed into law in the US in December 2016. The Act is designed to help accelerate medical product development and bring innovations and advances to patients who need them faster and efficiently. Under this Act, a new Regenerative Medicine Advanced Therapy designation has been established, along with a fast-track approval pathway for new regenerative medicine products. Considering this, the implementation of this Act can potentially result in the approval of new regenerative medicine products in the US and stimulate R&D in the field of regenerative medicine.

MarketsandMarkets™ View on Revenue: The global collagen and gelatin market is projected to reach USD 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7.0% during the forecast period.

Industry Segmentation in Detailed:

The orthopedic segment dominated the collagen and gelatin market in 2020:

Based on application, the global collagen market is segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care and others. The orthopedic segment accounted for the largest share of 37.5% of the collagen market and 41.5% of the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

The hospitals segment accounted for the largest share in 2020;

Based on end users, the collagen and gelatin market is segmented into hospitals and surgical centers. In 2020, the hospitals segment accounted for the largest share of 80.6% of both collagen and gelatin markets. The large share of this market segment is mainly because most surgical procedures worldwide are performed in hospitals due to the availability of advanced facilities and equipment and skilled surgeons.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

Leading Key Players Analysis:

Key players in the collagen and gelatin markets include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).

Geographical Trends in Detailed:

The Asia Pacific region is the fastest-growing region of the collagen and gelatin market in 2020.

The collagen and gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by rising geriatric population in Japan and China, increasing prevalence of chronic wounds, and growth in the number of people suffering from pressure ulcers.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122